News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
81 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (21242)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (92)
2 (55)
3 (1)
4 (4)
5 (65)
6 (116)
7 (86)
8 (101)
9 (46)
10 (4)
11 (5)
12 (90)
13 (97)
14 (81)
15 (116)
16 (43)
17 (1)
18 (12)
19 (98)
20 (90)
21 (83)
22 (111)
23 (47)
26 (66)
27 (70)
28 (93)
29 (55)
30 (39)
31 (2)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
26
27
28
29
30
31
Biotech Beach
Crinetics Pharmaceuticals Snags $63.5 Million in Series B Funding
Five months after its lead drug began Phase I testing San Diego-based Crinetics Pharmaceuticals has secured $63.5 million in Series B financing.
March 14, 2018
·
2 min read
·
Alex Keown
Drug Development
PharmaJet Releases Positive Phase I Results for Hantavirus Vaccines
PharmaJet released positive interim results from the U.S. Army’s Phase I clinical trial of two hantavirus vaccines to prevent hemorrhagic fever with renal syndrome (HFRS).
March 14, 2018
·
3 min read
·
Mark Terry
Genetown
Foghorn Therapeutics Launches with $50 Million
Foghorn Therapeutics has officially launched with a $50 million investment and the ambitious goal of altering the way our genes work.
March 14, 2018
·
2 min read
·
Mark Terry
Drug Development
8 Biotech Companies with Upcoming Catalysts
Here’s a look at eight biopharma companies with upcoming catalysts.
March 14, 2018
·
3 min read
·
Mark Terry
Policy
Right-To-Try Drug Bill Defeated in House
Federal right-to-try legislation that would have allowed terminally ill patients access to experimental therapies without approval from the U.S. Food and Drug Administration failed to muster enough support in the U.S. House of Representatives.
March 14, 2018
·
3 min read
·
Alex Keown
Policy
Theranos’ Elizabeth Holmes Charged with Fraud
Elizabeth Holmes, the founder of embattled biotech Theranos, and former company president Sunny Balwani have been charged with massive fraud by the U.S. Securities and Exchange Commission.
March 14, 2018
·
3 min read
·
Alex Keown
Drug Development
Auris Medical Fails Again in Phase III Trial
Auris Medical has gone down swinging again in attempting to develop a treatment for tinnitus after it announced its Phase III trial failed to meet endpoints.
March 14, 2018
·
2 min read
·
Alex Keown
Business
IQVIA Forms Alliance with Box to Provide Revolutionary, Cloud-Based Content Management Solutions to the Life Sciences and Healthcare Industries
IQVIA announced at the eyeforpharma conference that it has entered into an alliance with Box, a leading cloud content management platform provider.
March 14, 2018
·
2 min read
Biotech Bay
OptraSCAN Launches Third Generation On-Demand Digital Pathology® System at USCAP 2018
OptraSCAN announced its third generation On-Demand Digital Pathology® system for researchers and clinicians.
March 14, 2018
·
2 min read
Golden Meditech’s Largest Shareholder Acquired Additional 9,068,000 Shares
Golden Meditech Holdings Limited is pleased to announce that the Company’s largest shareholder Mr. Kam Yuen, Chairman and Chief Executive Officer of the Group, has further increased his shareholding in Golden Meditech.
March 14, 2018
·
1 min read
1 of 9
Next